Published in Biomed Mater on August 08, 2008
Bone Regeneration Based on Tissue Engineering Conceptions - A 21st Century Perspective. Bone Res (2013) 0.99
Electrospun PGS:PCL microfibers align human valvular interstitial cells and provide tunable scaffold anisotropy. Adv Healthc Mater (2014) 0.96
Effect of biodegradation and de novo matrix synthesis on the mechanical properties of valvular interstitial cell-seeded polyglycerol sebacate-polycaprolactone scaffolds. Acta Biomater (2012) 0.89
Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab. Mol Pharm (2013) 0.86
Tri-layered elastomeric scaffolds for engineering heart valve leaflets. Biomaterials (2014) 0.83
Nanofibrous substrates support colony formation and maintain stemness of human embryonic stem cells. J Cell Mol Med (2009) 0.81
Hemocompatibility of polymeric nanostructured surfaces. J Biomater Sci Polym Ed (2013) 0.81
Can bone tissue engineering contribute to therapy concepts after resection of musculoskeletal sarcoma? Sarcoma (2013) 0.81
Anisotropic poly (glycerol sebacate)-poly (ϵ-caprolactone) electrospun fibers promote endothelial cell guidance. Biofabrication (2014) 0.79
Nanoclay-enriched poly(ɛ-caprolactone) electrospun scaffolds for osteogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A (2014) 0.79
ECM inspired coating of embroidered 3D scaffolds enhances calvaria bone regeneration. Biomed Res Int (2014) 0.79
Polymeric endoaortic paving: Mechanical, thermoforming, and degradation properties of polycaprolactone/polyurethane blends for cardiovascular applications. Acta Biomater (2010) 0.78
The Recent Revolution in the Design and Manufacture of Cranial Implants: Modern Advancements and Future Directions. Neurosurgery (2015) 0.77
Aspirin-loaded electrospun poly(ε-caprolactone) tubular scaffolds: potential small-diameter vascular grafts for thrombosis prevention. J Mater Sci Mater Med (2012) 0.77
Functional Degradable Polymers by Radical Ring-Opening Copolymerization of MDO and Vinyl Bromobutanoate: Synthesis, Degradability and Post-Polymerization Modification. Biomacromolecules (2015) 0.76
Effects of polycaprolactone-based scaffolds on the blood-brain barrier and cerebral inflammation. Tissue Eng Part A (2015) 0.76
Data for accelerated degradation of calcium phosphate surface-coated polycaprolactone and polycaprolactone/bioactive glass composite scaffolds. Data Brief (2016) 0.75
Synchrotron-Based in Situ Characterization of the Scaffold Mass Loss from Erosion Degradation. J Funct Biomater (2016) 0.75
Bone Regeneration after Treatment with Covering Materials Composed of Flax Fibers and Biodegradable Plastics: A Histological Study in Rats. Biomed Res Int (2016) 0.75
Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics. Cancer Nanotechnol (2013) 0.75
Accelerated osteomesh resorption: a case report. Craniomaxillofac Trauma Reconstr (2010) 0.75
Encapsulation of Pseudomonas sp. ADP cells in electrospun microtubes for atrazine bioremediation. J Ind Microbiol Biotechnol (2012) 0.75
Fabrication of Cell-Loaded Two-Phase 3D Constructs for Tissue Engineering. Materials (Basel) (2016) 0.75
Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials (2002) 2.43
A novel 3D mammalian cell perfusion-culture system in microfluidic channels. Lab Chip (2007) 2.03
Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials (2010) 1.95
Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells (2006) 1.93
25th anniversary article: Engineering hydrogels for biofabrication. Adv Mater (2013) 1.54
Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells (2009) 1.49
A comparison of micro CT with other techniques used in the characterization of scaffolds. Biomaterials (2005) 1.47
The challenge of establishing preclinical models for segmental bone defect research. Biomaterials (2009) 1.43
Assessment of bone ingrowth into porous biomaterials using MICRO-CT. Biomaterials (2007) 1.43
An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials (2010) 1.42
Electro-spinning of pure collagen nano-fibres - just an expensive way to make gelatin? Biomaterials (2008) 1.40
Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells (2008) 1.37
Tissue engineering of articular cartilage with biomimetic zones. Tissue Eng Part B Rev (2009) 1.30
Combining electrospun scaffolds with electrosprayed hydrogels leads to three-dimensional cellularization of hybrid constructs. Biomacromolecules (2008) 1.28
A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci Transl Med (2012) 1.26
Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repair. Biomaterials (2009) 1.23
Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res A (2009) 1.19
Repair and regeneration of osteochondral defects in the articular joints. Biomol Eng (2007) 1.16
Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts. Biomaterials (2006) 1.15
Evaluation of a hybrid scaffold/cell construct in repair of high-load-bearing osteochondral defects in rabbits. Biomaterials (2005) 1.15
Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in a rabbit model. Tissue Eng (2006) 1.13
Analysis of 3D bone ingrowth into polymer scaffolds via micro-computed tomography imaging. Biomaterials (2004) 1.12
Gelatin-methacrylamide hydrogels as potential biomaterials for fabrication of tissue-engineered cartilage constructs. Macromol Biosci (2013) 1.11
The challenge to measure cell proliferation in two and three dimensions. Tissue Eng (2005) 1.10
The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application. Biomaterials (2012) 1.10
Surface modification of ultra thin poly (epsilon-caprolactone) films using acrylic acid and collagen. Biomaterials (2004) 1.10
Silk fibroin in ocular tissue reconstruction. Biomaterials (2011) 1.09
Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects. Bone (2011) 1.09
Engineered silk fibroin protein 3D matrices for in vitro tumor model. Biomaterials (2010) 1.09
Effect of culture conditions and calcium phosphate coating on ectopic bone formation. Biomaterials (2013) 1.09
Discrepancies between metabolic activity and DNA content as tool to assess cell proliferation in cancer research. J Cell Mol Med (2010) 1.08
Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment. PLoS One (2012) 1.08
Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment. Biomaterials (2010) 1.08
The correlation of pore morphology, interconnectivity and physical properties of 3D ceramic scaffolds with bone ingrowth. Biomaterials (2008) 1.08
Current strategies for cell delivery in cartilage and bone regeneration. Curr Opin Biotechnol (2004) 1.07
Neo-vascularization and bone formation mediated by fetal mesenchymal stem cell tissue-engineered bone grafts in critical-size femoral defects. Biomaterials (2009) 1.07
Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL-TCP scaffolds. Biomaterials (2010) 1.07
Human corneal epithelial equivalents constructed on Bombyx mori silk fibroin membranes. Biomaterials (2011) 1.06
The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (epsilon-caprolactone)/collagen fibers and hyaluronic acid hydrogel. Biomaterials (2011) 1.05
Review: development of clinically relevant scaffolds for vascularised bone tissue engineering. Biotechnol Adv (2012) 1.04
Mineralization capacity of Runx2/Cbfa1-genetically engineered fibroblasts is scaffold dependent. Biomaterials (2006) 1.03
Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds. Tissue Eng Part A (2009) 1.03
Tissue-engineering approach to the repair and regeneration of tendons and ligaments. Tissue Eng (2003) 1.03
Co-culture of bone marrow fibroblasts and endothelial cells on modified polycaprolactone substrates for enhanced potentials in bone tissue engineering. Tissue Eng (2006) 1.02
Co-culture of umbilical cord blood CD34+ cells with human mesenchymal stem cells. Tissue Eng (2006) 1.01
A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone. Dis Model Mech (2014) 1.00
Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells. Stem Cells Dev (2009) 0.99
Alterations of human acellular tissue matrix by gamma irradiation: histology, biomechanical property, stability, in vitro cell repopulation, and remodeling. J Biomed Mater Res B Appl Biomater (2008) 0.98
A biphasic scaffold design combined with cell sheet technology for simultaneous regeneration of alveolar bone/periodontal ligament complex. Biomaterials (2012) 0.96
Direct writing by way of melt electrospinning. Adv Mater (2011) 0.96
Scaffold design and in vitro study of osteochondral coculture in a three-dimensional porous polycaprolactone scaffold fabricated by fused deposition modeling. Tissue Eng (2003) 0.95
The effect of unlocking RGD-motifs in collagen I on pre-osteoblast adhesion and differentiation. Biomaterials (2010) 0.95
Retracted Sphingosine-1-phosphate mediates proliferation maintaining the multipotency of human adult bone marrow and adipose tissue-derived stem cells. J Mol Cell Biol (2010) 0.95
Mandibular defect reconstruction using three-dimensional polycaprolactone scaffold in combination with platelet-rich plasma and recombinant human bone morphogenetic protein-2: de novo synthesis of bone in a single case. Tissue Eng Part A (2009) 0.95
Advanced tissue engineering scaffold design for regeneration of the complex hierarchical periodontal structure. J Clin Periodontol (2014) 0.94
Effects of Runx2 genetic engineering and in vitro maturation of tissue-engineered constructs on the repair of critical size bone defects. J Biomed Mater Res A (2006) 0.94
A biomimetic extracellular matrix for cartilage tissue engineering centered on photocurable gelatin, hyaluronic acid and chondroitin sulfate. Acta Biomater (2013) 0.94
The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells. Biomaterials (2009) 0.93
Biological performance of a polycaprolactone-based scaffold used as fusion cage device in a large animal model of spinal reconstructive surgery. Biomaterials (2009) 0.93
Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model. Organogenesis (2011) 0.93
Near-field effects on coherent anti-Stokes Raman scattering microscopy imaging. Opt Express (2007) 0.92
In vivo efficacy of bone-marrow-coated polycaprolactone scaffolds for the reconstruction of orbital defects in the pig. J Biomed Mater Res B Appl Biomater (2003) 0.92
Strategies for zonal cartilage repair using hydrogels. Macromol Biosci (2009) 0.92
A dual-layer silk fibroin scaffold for reconstructing the human corneal limbus. Biomaterials (2012) 0.91
Establishment of a preclinical ovine model for tibial segmental bone defect repair by applying bone tissue engineering strategies. Tissue Eng Part B Rev (2010) 0.91
Polycaprolactone scaffold and reduced rhBMP-7 dose for the regeneration of critical-sized defects in sheep tibiae. Biomaterials (2013) 0.90
Ovine bone- and marrow-derived progenitor cells and their potential for scaffold-based bone tissue engineering applications in vitro and in vivo. J Tissue Eng Regen Med (2010) 0.90
Surface modification of PCL-TCP scaffolds in rabbit calvaria defects: Evaluation of scaffold degradation profile, biomechanical properties and bone healing patterns. J Biomed Mater Res A (2010) 0.89
Porous scaffold architecture guides tissue formation. J Bone Miner Res (2012) 0.89
Using extracellular matrix for regenerative medicine in the spinal cord. Biomaterials (2013) 0.89
Cell sourcing for bone tissue engineering: amniotic fluid stem cells have a delayed, robust differentiation compared to mesenchymal stem cells. Stem Cell Res (2011) 0.89
Polycaprolactone-based fused deposition modeled mesh for delivery of antibacterial agents to infected wounds. Biomaterials (2010) 0.89
Colonization and osteogenic differentiation of different stem cell sources on electrospun nanofiber meshes. Tissue Eng Part A (2010) 0.89
Application of a polyelectrolyte complex coacervation method to improve seeding efficiency of bone marrow stromal cells in a 3D culture system. Biomaterials (2005) 0.89
A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer. Biomaterials (2013) 0.89
Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial model. J Mol Histol (2007) 0.89
Response of cells on surface-induced nanopatterns: fibroblasts and mesenchymal progenitor cells. Biomacromolecules (2007) 0.88
Contrasting effects of vasculogenic induction upon biaxial bioreactor stimulation of mesenchymal stem cells and endothelial progenitor cells cocultures in three-dimensional scaffolds under in vitro and in vivo paradigms for vascularized bone tissue engineering. Tissue Eng Part A (2012) 0.87
Review of vascularised bone tissue-engineering strategies with a focus on co-culture systems. J Tissue Eng Regen Med (2012) 0.87
Dermal fibroblast infiltration of poly(ε-caprolactone) scaffolds fabricated by melt electrospinning in a direct writing mode. Biofabrication (2013) 0.87
The sphenozygomatic suture as a key site for osteosynthesis of the orbitozygomatic complex in panfacial fractures: a biomechanical study in human cadavers based on clinical practice. Plast Reconstr Surg (2002) 0.87
Surface modification of a polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU) nanocomposite polymer as a stent coating for enhanced capture of endothelial progenitor cells. Biointerphases (2013) 0.86
Development of cell-selective films for layered co-culturing of vascular progenitor cells. Biomaterials (2009) 0.86
Osteogenic and adipogenic induction potential of human periodontal cells. J Periodontol (2008) 0.85
Non-invasive identification of proteoglycans and chondrocyte differentiation state by Raman microspectroscopy. J Biophotonics (2012) 0.85
Viability and adipogenic potential of human adipose tissue processed cell population obtained from pump-assisted and syringe-assisted liposuction. J Dermatol Sci (2005) 0.85
Single-cell force spectroscopy, an emerging tool to quantify cell adhesion to biomaterials. Tissue Eng Part B Rev (2013) 0.85
Efficacy of glow discharge gas plasma treatment as a surface modification process for three-dimensional poly (D,L-lactide) scaffolds. J Biomed Mater Res A (2003) 0.84
Vasculogenic and osteogenesis-enhancing potential of human umbilical cord blood endothelial colony-forming cells. Stem Cells (2012) 0.84
Administration of PTH and ibandronate increases ovariectomized rat compact bone viscoelasticity. J Mech Behav Biomed Mater (2013) 0.84
In vivo evaluation of an ultra-thin polycaprolactone film as a wound dressing. J Biomater Sci Polym Ed (2007) 0.84
Processing of polycaprolactone and polycaprolactone-based copolymers into 3D scaffolds, and their cellular responses. Tissue Eng Part A (2009) 0.83
Discontinuous release of bone morphogenetic protein-2 loaded within interconnected pores of honeycomb-like polycaprolactone scaffold promotes bone healing in a large bone defect of rabbit ulna. Tissue Eng Part A (2011) 0.83
Vitreous cryopreservation of nanofibrous tissue-engineered constructs generated using mesenchymal stromal cells. Tissue Eng Part C Methods (2009) 0.83
Perspectives in multiphasic osteochondral tissue engineering. Anat Rec (Hoboken) (2013) 0.83
Biomaterials/scaffolds. Design of bioactive, multiphasic PCL/collagen type I and type II-PCL-TCP/collagen composite scaffolds for functional tissue engineering of osteochondral repair tissue by using electrospinning and FDM techniques. Methods Mol Med (2007) 0.83
Design and fabrication of tubular scaffolds via direct writing in a melt electrospinning mode. Biointerphases (2012) 0.83
Cryopreservation of alginate-fibrin beads involving bone marrow derived mesenchymal stromal cells by vitrification. Biomaterials (2008) 0.83
Delineating breast cancer cell interactions with engineered bone microenvironments. J Bone Miner Res (2013) 0.83
Evaluation of methods for cultivating limbal mesenchymal stromal cells. Cytotherapy (2012) 0.83